Updated on 14 April 2014
Focus areas include research in life sciences, healthcare and applied markets, such as cancer and diagnostics
Singapore: Thermo Fisher Scientific and National University of Singapore (NUS) have entered into a strategic alliance to advance basic and applied research in Singapore for future discoveries and development of applications.
The alliance will identify and promote high-impact research that will advance knowledge and contribute to the betterment of society. As a part of the agreement, for up to five years, Thermo Fisher Scientific will sponsor both multi-year and short term research grants in the life sciences, and will also support collaborative interactions with NUS, including a joint symposium to accelerate scientific knowledge exchange in the biological and physical sciences.
Focus areas include research in life sciences, healthcare and applied markets, such as cancer and diagnostics. These programmes will also pursue development of analytical technologies, reagents, instrumentation, and software for life sciences, healthcare and the environment.
Thermo Fisher Scientific focuses intently on enabling customer innovation and productivity. Through its Life Sciences Solutions Group, and the strategic alliance with NUS, Thermo Fisher Scientific will broaden and deepen its research and development commitment to Singapore and the entire Asia-Pacific region. The NUS Industry Liaison Office, which is part of NUS Enterprise, facilitated this industry partnership.
"This interest and investment in NUS by Thermo Fisher Scientific is an important affirmation and validation of the value and relevance of NUS' research and expertise to the life sciences industry and healthcare sector," said Professor Barry Halliwell, NUS Deputy President (Research and Technology).